Exercising your Ethics
The Case of Orphan Drugs
The Situation
You are an executive at a major U.S. pharmaceutical firm. A team of your employees has been conducting research into new drugs for acid reflux, a common ailment. The researchers were surprised to discover that one of the investigational pharmaceuticals was effective at treating a rare neurological disorder, although it was completely ineffective at treating acid reflux. The research team is elated with their discovery and would like the company to move forward with clinical trials, FDA approval, and commercialization.
The Dilemma
You are the financial manager for the pharmaceutical company and the CEO is asking for your recommendation about moving ahead with clinical trials of this ...
Get Business Essentials, 12/e now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
